"Alongside every strong woman, is an army of additional women whose inner strength blossoms."      sherrie palm

APOPS FOUNDER SHERRIE PALM

Sherrie Palm is the Founder/CEO/Executive Director of Association for Pelvic Organ Prolapse Support (APOPS), a pelvic organ prolapse (POP) Key Opinion Leader, author of award winning book Pelvic Organ Prolapse: The Silent Epidemic, and an international advocate and public speaker on women's health empowerment and multiple aspects of pelvic organ prolapse quality of life impact. Sherrie’s points of focus are generating global POP awareness, developing guidance and support structures for women navigating POP, and bridge building within POP healthcare, research, academia, industry, and policy sectors toward the evolution of POP directives. 

Sherrie Palm's journey began in December 2007, with her diagnosis of pelvic organ prolapse. Upon returning home and researching POP, Sherrie discovered how common the condition is, that it had been medically documented for nearly 4000 years, and that stigma continued to shroud the condition in silence. In an effort to increase awareness of pelvic organ prolapse, Sherrie wrote the first edition of Pelvic Organ Prolapse: The Silent Epidemic, which was published in in April 2009. Information on them 3rd edition is available here. While marketing the first edition, Sherrie recognized the most effective way to educate women about pelvic organ prolapse was to found a nonprofit, and in 2010, APOPS became a federally recognized 501(c)(3) nonprofit agency. 

Contact Sherrie Palm regarding presenting at your event via APOPS landline at 262-642-4338; additional contact info available on Speaker Onesheet. 

Sherrie Palm Bio

Sherrie Palm Speaker Onesheet

Sherrie Palm CV

FDA Mesh Presentation September 2011

 
APOPS conference 2.jpg

 

CLINICIAN OUTREACH

Misconceptions abound in the field of pelvic organ prolapse. To advance POP understanding, we must clarify the reality of impact to quality of life to enable clinicians to recognize misconceptions. Diagnostic clinicians are currently poorly educated about pelvic organ prolapse. Despite childbirth and menopause being the leading causes of POP, women are currently not screened for the condition during routine pelvic exams. 

 
Sher Coloplast image cropped.png

 

INDUSTRY OUTREACH

It is imperative all sectors engaged in the POP arena bridge together to recognize, evaluate, and address pelvic organ prolapse. Industry develops both surgical and non-surgical treatments, and it is imperative they understand the needs of women navigating pelvic organ prolapse. 

 
AUA 2016.jpg

 

LEGISLATIVE PRIORITIES

Policy is a key aspect of the evolution of POP awareness, diagnosis, treatment, and research. Representing the needs of women at legislative priority meetings is a pivotal aspect of generating much needed evolution in all aspects of pelvic organ prolapse diagnostics and treatment.